Related Experiment Video
Updated: Jun 5, 2026

An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota
Published on: July 31, 2019
Meta-analysis: the effects of gut flora modulation using prebiotics, probiotics and synbiotics on minimal hepatic
S Shukla1, A Shukla, S Mehboob
1Department of Medicine, University at Buffalo, State University of New York, Buffalo, NY, USA.
Background:
Minimal hepatic encephalopathy (MHE) is characterised by subtle neurocognitive deficits without overt clinical manifestations. Although several trials have individually evaluated the role of prebiotics, probiotics and synbiotics, there is yet no consensus on the management of MHE.
Aim:
To estimate the efficacy of prebiotics, probiotics and synbiotics in MHE in randomised controlled trials.
Methods:
MEDLINE, EMBASE, CINAHL and the Cochrane Database of Systematic Reviews were searched for published studies in all languages. Inclusion and exclusion criteria were defined a priori. Pooled relative risk and heterogeneity were estimated as the measures of association.
Results:
Nine studies met our inclusion criteria. Use of prebiotics, probiotics and synbiotics significantly reduced the pooled relative risk (RR) of no improvement of MHE (RR 0.40, 95% CI 0.32-0.50; P<0.001). Upon subgroup analysis, five studies with lactulose showed significant reduction of risk of no improvement of MHE (RR 0.34, 95% CI 0.24-0.47; P<0.0001) with no inter-trial heterogeneity. In two trials each of probiotics and synbiotics, their use was associated with significant beneficial effects (RR 0.41, 95% CI 0.26-0.65; P<0.0001 and RR of 0.51, 95% CI 0.32-0.80; P=0.004 respectively). There were no major adverse events though probiotics and synbiotics were better tolerated than lactulose.
Conclusions:
The use of prebiotics, probiotics and synbiotics was associated with significant improvement in minimal hepatic encephalopathy. Among individual agents, lactulose appears to have the most beneficial effect, followed closely by probiotics and synbiotics.
Insights
Prebiotics, probiotics, and synbiotics significantly improve minimal hepatic encephalopathy (MHE). Lactulose showed the most benefit, followed by probiotics and synbiotics, with no major adverse events reported.
Area of Science:
- Gastroenterology and Hepatology
- Neuroscience
- Microbiology
Background:
- Minimal hepatic encephalopathy (MHE) presents with subtle neurocognitive deficits.
- Current management strategies for MHE lack a definitive consensus.
- Individual trials on prebiotics, probiotics, and synbiotics exist but require synthesis.
Purpose of the Study:
- To systematically evaluate the efficacy of prebiotics, probiotics, and synbiotics in managing MHE.
- To synthesize findings from randomized controlled trials (RCTs) on these interventions.
- To establish a consensus on the management of MHE using gut microbiota-modulating agents.
Main Methods:
- Comprehensive literature search across MEDLINE, EMBASE, CINAHL, and Cochrane Database.
- Inclusion and exclusion criteria were predefined for study selection.
- Pooled relative risk and heterogeneity were calculated to assess treatment effects.
Main Results:
- Nine RCTs met the inclusion criteria.
- Prebiotics, probiotics, and synbiotics significantly reduced the risk of MHE non-improvement (RR 0.40).
- Lactulose demonstrated the strongest effect (RR 0.34), followed by probiotics (RR 0.41) and synbiotics (RR 0.51).
Conclusions:
- Prebiotics, probiotics, and synbiotics are effective in improving MHE.
- Lactulose, probiotics, and synbiotics offer significant benefits for MHE management.
- These agents are well-tolerated, with probiotics and synbiotics showing better tolerance than lactulose.
Related Concept Videos
Hepatic Encephalopathy
Microbiota Modulation by Antibiotics
Probiotics
Gut-Brain Axis
Dysbiosis of the Gut Microbiota
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
